Insider Transactions Reported by 15 Insiders of Lineage Cell Therapeutics, Inc.

Symbol
LCTX on NYSE
Location
Carlsbad, CA

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

Lineage Cell Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BROADWOOD PARTNERS, L.P. Director, 10%+ Owner $75,332,708 27 Jan 2025
Brian M. Culley President and CEO, Director $432,928 05 Mar 2026
Michael H. Mulroy Director $168,982 01 Jul 2025
DON M. BAILEY Director $165,153 01 Jul 2024
George A. Samuel III General Counsel and Secretary $55,913 05 Mar 2026
Neal C. Bradsher Director, 10%+ Owner $52,500 01 Jul 2025
Anula Jayasuriya Director 01 Jul 2025
Angus C. Russell Director 01 Jul 2025
Dipti Amin Director 01 Jul 2025
DEBORAH J. ANDREWS Director 01 Jul 2025
Kevin Leon Cook Chief Financial Officer 10 Mar 2022
ALFRED D. KINGSLEY Chairman, Director 01 Jul 2023
Gary S. Hogge SVP,Clinical & Medical Affairs 09 Mar 2023
Alexandra Hernandez Sr Director Finance/Controller 07 Jul 2022
Jill A. Howe Chief Financial Officer 05 Mar 2026

Recent Insider Transactions by Companies or Individuals for Lineage Cell Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.